• SPX
  • $5,544.59
  • -0.78 %
  • -$43.68
  • DJI
  • $40,665.02
  • -1.29 %
  • -$533.08
  • N225
  • $39,952.62
  • -0.43 %
  • -$173.73
  • FTSE
  • $8,204.89
  • 0.21 %
  • $17.43
  • IXIC
  • $17,871.22
  • -0.7 %
  • -$125.70

Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News & Analysis

Currency in USD Disclaimer

$111.42

$0.37

(0.33%)

Day's range
$110.49
$113.87
52 wk range
$102
$143.24
50-day range
$105.37
$122.25
  • Country: US
  • ISIN: US98956P1021
ZBH Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 2.92
  • Piotroski Score 7.00
  • Grade Hold
  • Symbol (ZBH)
  • Company Zimmer Biomet Holdings, Inc.
  • Price $111.42
  • Changes Percentage (0.33%)
  • Change $0.37
  • Day Low $110.49
  • Day High $113.87
  • Year High $143.24

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

  • Last Earnings 05/13/2024
  • Ex-Dividend for 5/16 Dividend 06/26/2024
  • Dividend Payable 07/31/2024
  • Today N/A
  • Next Earnings (Estimated) 08/07/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $138.50
  • High Stock Price Target $190.00
  • Low Stock Price Target $115.00
  • Potential Upside/Downside N/A
  • Consensus Rating Buy
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $4.61
  • Trailing P/E Ratio 24.59
  • Forward P/E Ratio 24.59
  • P/E Growth 24.59
  • Net Income $1.02 B

Income Statement

Quarterly

Annual

Latest news of ZBH

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.